Russell, M
While all GLP-1 receptor agonists effectively lower hemoglobin A1c and promote weight loss, there are meaningful differences in their magnitude of effect, titration schedules, and adverse effect profiles that influence clinical decision-making
Patients with a history of chronic pancreatitis, pancreatic cancer, or other significant pancreatic disorders may not be suitable candidates for this therapy
Pregnant or breastfeeding women, people with copper metabolism disorders like Wilsons disease, and anyone with active skin infections should speak with a doctor before starting
GLP-1 medications drive changes in two distinct ways: through the direct effects of the drug on your digestive system, and through the body composition changes that come with significant weight loss
Are there potential health benefits of semaglutide for teens